DLB: Dolby Laboratories, Inc. Stock

SIC 6794 – Patent Owners and Lessors

Valuation
Market Cap ($M) 7,888.12
Enterprise Value ($M) 7,247.77
Book Value ($M) 2,362.31
Book Value / Share 24.72
Price / Book 3.34
NCAV ($M) 878.14
NCAV / Share 9.19
Price / NCAV 8.98

Profitability (mra)
Return on Invested Capital (ROIC) 0.08
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.08

Liquidity (mrq)
Quick Ratio 3.59
Current Ratio 3.68

Balance Sheet (mrq) ($M)
Current Assets 1,451.36
Assets 2,935.53
Liabilities 573.22
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,299.74
Operating Income 262.81
Net Income 200.66
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 367.08
Cash from Investing 54.21
Cash from Financing -236.81

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 10.80 6.36
02-13 13G/A Kayne Anderson Rudnick Investment Management Llc 9.19 6.07
02-08 13G/A Morgan Stanley 7.80 7.78
01-24 13G/A BlackRock Inc. 9.80 85.96

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 29, 2023 ☐ TRANSITION REPORT PURSUANT
2023-11-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 29, 2023 ☐ TRANSITION REPORT PURSUANT TO SECT
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 33,472 171,136 19.56
2024-03-26 43,461 187,809 23.14
2024-03-25 48,450 208,736 23.21
2024-03-22 38,408 224,786 17.09

(click for more detail)

Similar Companies
CXW – CoreCivic, Inc. DEA – Easterly Government Properties, Inc.
DEI – Douglas Emmett, Inc. DLR – Digital Realty Trust, Inc.
DOC – Healthpeak Properties, Inc.


Financial data and stock pages provided by
Fintel.io